Search Stock News and Analysis

Nektar Therapeutics Pullback May Be Short-Lived

https://www.schaeffersresearch.com/content/analysis/2020/01/23/nektar-therapeutics-pullback-may-be-short-lived

1/23/2020 11:43 AM

Biopharmaceutical stock Nektar Therapeutics (NASDAQ:NKTR) is down 0.5% this afternoon, last seen at $22.02. NKTR has recently struggled to gain momentum, but earlier this month touched its highest in...

Nektar Therapeutics Options Pop as Stock Soars

https://www.schaeffersresearch.com/content/options/2020/01/10/nektar-therapeutics-options-pop-as-stock-soars

1/10/2020 1:34 PM

The shares of Nektar Therapeutics (NASDAQ:NKTR) are pacing for their biggest one-day jump in almost two years after the firm amended its collaboration agreement with Bristol-Myers Squibb (BMY). The t...

S&P 500 Addition Bolsters Struggling LVS Stock

https://www.schaeffersresearch.com/content/news/2019/09/27/s-p-500-addition-bolsters-struggling-lvs-stock

9/27/2019 9:35 AM

It was announced last night that casino name Las Vegas Sands Corp. (NYSE:LVS) will be joining the S&P 500 Index (SPX), replacing Nektar Therapeutics (NKTR), which is headed to the S&P MidCap 400 Inde...

Nektar Therapeutics Blasted With Bear Notes During Sell-Off

https://www.schaeffersresearch.com/content/news/2019/08/09/nektar-therapeutics-blasted-with-bear-notes-during-sell-off

8/9/2019 10:04 AM

Nektar Therapeutics (NASDAQ:NKTR) stock opened at its lowest level since mid-2017 today -- down 36% at $18.01 -- after the drugmaker unveiled manufacturing issues with bempeg, its experimental cancer ...

Nektar Stock on the Mend Thanks to FDA News

https://www.schaeffersresearch.com/content/analysis/2019/08/01/nektar-stock-on-the-mend-thanks-to-fda-news

8/1/2019 12:19 PM

A big winner out of the healthcare sector today is Nektar Therapeutics (NASDAQ:NKTR), after the Food and Drug Administration (FDA) granted "breakthrough" therapy status to the company's lead cancer dr...

PEOPLE ALSO SEARCH FOR